TSS
KYMR icon

Two Sigma Securities’s Kymera Therapeutics KYMR Stock Holding History

Two Sigma Securities’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$311K Buy
+2,716
New +$233K 0.03% 850

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Two Sigma Securities's KYMR Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Kymera Therapeutics (KYMR) in Q2 2026: 2,716 shares worth $311K. The stake represents 0.03% of the portfolio and ranks #850 among its holdings.

275 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Two Sigma Securities held 2,716 shares of Kymera Therapeutics worth $311K as of Q2 2026.
  • Kymera Therapeutics was a new Two Sigma Securities position in Q2 2026.
  • Kymera Therapeutics made up 0.03% of Two Sigma Securities's portfolio in Q2 2026, its #850 holding.
  • 275 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.